The SVP & GC of Cambrex (CBM) is Buying Shares


Today, the SVP & GC of Cambrex (CBM), Samantha Hanley, bought shares of CBM for $3.39M.

In addition to Samantha Hanley, 10 other CBM executives reported Buy trades in the last month.

See today’s analyst top recommended stocks >>

Based on Cambrex’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $149 million and quarterly net profit of $9.55 million. In comparison, last year the company earned revenue of $105 million and had a net profit of $26.73 million. The company has a one-year high of $60.29 and a one-year low of $33.80. Currently, Cambrex has an average volume of 423.21K.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts